Terms: = Lymphoma AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3
14 results:
1. The evaluation of gene mutation profiles by next-generation sequencing in diffuse large B-cell lymphoma.
Özçalımlı A; Erdoğdu İH; Turgutkaya A; Yavaşoğlu İ; Döger FK; Bolaman AZ
Int J Lab Hematol; 2023 Jun; 45(3):310-316. PubMed ID: 36576110
[TBL] [Abstract] [Full Text] [Related]
2. Intravascular NK/T-cell lymphoma: clinicopathological and integrated molecular analysis of two cases provides a clue to disease pathogenesis.
Fujikura K; Yamashita D; Sakamoto R; Ishikawa T; Chuang SS; Itoh T; Imai Y
J Clin Pathol; 2019 Sep; 72(9):642-646. PubMed ID: 31123138
[TBL] [Abstract] [Full Text] [Related]
3. Genes, Proteins, and Biological Pathways Preventing Chromothripsis.
Poot M
Methods Mol Biol; 2018; 1769():231-251. PubMed ID: 29564828
[TBL] [Abstract] [Full Text] [Related]
4. wrn-targeted therapy using inhibitors NSC 19630 and NSC 617145 induce apoptosis in HTLV-1-transformed adult T-cell leukemia cells.
Moles R; Bai XT; Chaib-Mezrag H; Nicot C
J Hematol Oncol; 2016 Nov; 9(1):121. PubMed ID: 27829440
[TBL] [Abstract] [Full Text] [Related]
5. Expression of MLL-AF4 or AF4-MLL fusions does not impact the efficiency of DNA damage repair.
Castaño J; Herrero AB; Bursen A; González F; Marschalek R; Gutiérrez NC; Menendez P
Oncotarget; 2016 May; 7(21):30440-52. PubMed ID: 27119507
[TBL] [Abstract] [Full Text] [Related]
6. Polymorphisms in DNA repair genes, hair dye use, and the risk of non-Hodgkin lymphoma.
Guo H; Bassig BA; Lan Q; Zhu Y; Zhang Y; Holford TR; Leaderer B; Boyle P; Qin Q; Zhu C; Li N; Rothman N; Zheng T
Cancer Causes Control; 2014 Oct; 25(10):1261-70. PubMed ID: 25178586
[TBL] [Abstract] [Full Text] [Related]
7. Polymorphisms in DNA repair genes and MDR1 and the risk for non-Hodgkin lymphoma.
Kim HN; Kim NY; Yu L; Kim YK; Lee IK; Yang DH; Lee JJ; Shin MH; Park KS; Choi JS; Kim HJ
Int J Mol Sci; 2014 Apr; 15(4):6703-16. PubMed ID: 24756092
[TBL] [Abstract] [Full Text] [Related]
8. Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma.
Chen Y; Zheng T; Lan Q; Kim C; Qin Q; Foss F; Chen X; Holford T; Leaderer B; Boyle P; Wang C; Dai M; Liu Z; Ma S; Chanock SJ; Rothman N; Zhang Y
Am J Hematol; 2013 Jul; 88(7):606-11. PubMed ID: 23619945
[TBL] [Abstract] [Full Text] [Related]
9. Association of GSTT1 polymorphism with acute myeloid leukemia risk is dependent on smoking status.
Kim HN; Kim NY; Yu L; Tran HT; Kim YK; Lee IK; Shin MH; Park KS; Choi JS; Kim HJ
Leuk Lymphoma; 2012 Apr; 53(4):681-7. PubMed ID: 21942242
[TBL] [Abstract] [Full Text] [Related]
10. Association of follicular lymphoma risk with BRCA2 N372H polymorphism in Slovak population.
Salagovič J; Klimčáková L; Ilenčíková D; Kafková A
Med Oncol; 2012 Jun; 29(2):1173-8. PubMed ID: 21476145
[TBL] [Abstract] [Full Text] [Related]
11. Cdk2 suppresses cellular senescence induced by the c-myc oncogene.
Campaner S; Doni M; Hydbring P; Verrecchia A; Bianchi L; Sardella D; Schleker T; Perna D; Tronnersjö S; Murga M; Fernandez-Capetillo O; Barbacid M; Larsson LG; Amati B
Nat Cell Biol; 2010 Jan; 12(1):54-9; sup pp 1-14. PubMed ID: 20010815
[TBL] [Abstract] [Full Text] [Related]
12. Polymorphisms in DNA repair genes and risk of non-Hodgkin lymphoma among women in Connecticut.
Shen M; Zheng T; Lan Q; Zhang Y; Zahm SH; Wang SS; Holford TR; Leaderer B; Yeager M; Welch R; Kang D; Boyle P; Zhang B; Zou K; Zhu Y; Chanock S; Rothman N
Hum Genet; 2006 Jul; 119(6):659-68. PubMed ID: 16738949
[TBL] [Abstract] [Full Text] [Related]
13. Severe toxicity following induction chemotherapy for acute myelogenous leukemia in a patient with Werner's syndrome.
Seiter K; Qureshi A; Liu D; Galvin-Parton P; Arshad M; Agoliati G; Ahmed T
Leuk Lymphoma; 2005 Jul; 46(7):1091-5. PubMed ID: 16019564
[TBL] [Abstract] [Full Text] [Related]
14. Functional link between Myc and the Werner gene in tumorigenesis.
Grandori C; Robinson KL; Galloway DA; Swisshelm K
Cell Cycle; 2004 Jan; 3(1):22-5. PubMed ID: 14657658
[TBL] [Abstract] [Full Text] [Related]
